Johnson and Johnson to exit insulin pump marketTuesday, 16 January 2018
Johnson and Johnson (JNJ) have announced their intention to exit the insulin pump market globally.
AMSL Diabetes will continue to offer the full range of Dexcom CGM, Lifescan blood glucose meters, HypoPak fast acting glucose and accessory products.
If you currently have an Animas pump ASML will support users for the length of their warranty. There are still Animas pumps available for purchase. Any new pumps will also be supported for the four year warranty period.
Consumables will continue to be available on the NDSS for the foreseeable future.
For more information on how this announcement may affect you please contact AMSL Diabetes on 1300 851 056 or email email@example.com.